INSULIN ASPART INJECTION

INSULIN ASPART INJECTION was reported 2718 times

INSULIN ASPART INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 45 0.2273
1 ANTACID THERAPY 29 0.2231
2 DIABETIC DYSLIPIDAEMIA 2 0.2000
3 APPENDICOLITH 72 0.1860
4 ANALGESIC THERAPY 49 0.1526
5 DRUG THERAPY 48 0.1416
6 ANTICOAGULANT THERAPY 29 0.1021
7 CONGENITAL HIATUS HERNIA 23 0.1009
8 MALIGNANT MELANOMA STAGE 0 21 0.1005
9 LYSOZYME INCREASED 2 0.0833
10 BACTEROIDES INFECTION 21 0.0805
11 OCCUPATIONAL EXPOSURE TO AIR CONTAMINANTS 3 0.0682
12 ANAL ULCER HAEMORRHAGE 2 0.0667
13 PRODUCT GEL FORMATION 8 0.0656
14 CONGENITAL BLADDER ANOMALY 7 0.0519
15 GENITALIA EXTERNAL AMBIGUOUS 7 0.0405
16 CARBOHYDRATE METABOLISM DISORDER 2 0.0345
17 INCREASED INSULIN REQUIREMENT 7 0.0295
18 ANTI-INSULIN ANTIBODY 2 0.0290
19 DEXTROCARDIA 5 0.0266
20 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 23 0.0248
21 HYPERPHOSPHATAEMIA 52 0.0242
22 CEREBRAL CAVERNOUS MALFORMATION 1 0.0222
23 BLOOD POTASSIUM 1 0.0222
24 BLOOD PHOSPHORUS INCREASED 60 0.0220
25 NEONATAL RESPIRATORY DEPRESSION 7 0.0211
26 BIOPSY BRAIN ABNORMAL 1 0.0200
27 ADVERSE EVENT FOLLOWING IMMUNISATION 1 0.0179
28 TOTAL LUNG CAPACITY DECREASED 28 0.0175
29 BLOOD KETONE BODY PRESENT 3 0.0160
30 PRODUCT CONTAMINATION WITH BODY FLUID 3 0.0146
31 CARDIAC DEVICE IMPLANTATION 1 0.0137
32 INSULIN RESISTANCE 28 0.0134
33 CONGENITAL DIAPHRAGMATIC HERNIA 5 0.0128
34 OEDEMATOUS PANCREATITIS 7 0.0125
35 SPLENIC THROMBOSIS 2 0.0118
36 DIABETIC METABOLIC DECOMPENSATION 16 0.0115
37 CATHETER SITE ABSCESS 2 0.0115
38 POSTPRANDIAL HYPOGLYCAEMIA 2 0.0107
39 BURNOUT SYNDROME 6 0.0105
40 BILE OUTPUT INCREASED 1 0.0105
41 BLOOD KETONE BODY INCREASED 8 0.0102
42 LUNG OPACITY 27 0.0102
43 FOETAL HYPOKINESIA 7 0.0100
44 HYPOGLYCAEMIC SEIZURE 9 0.0099
45 STARVATION KETOACIDOSIS 2 0.0099
46 BLOOD URIC ACID INCREASED 55 0.0095
47 AORTIC STENOSIS 33 0.0095
48 ACUTE ON CHRONIC LIVER FAILURE 2 0.0093
49 ABORTION EARLY 1 0.0093
50 HYPOGLYCAEMIC UNCONSCIOUSNESS 18 0.0091
51 LIQUID PRODUCT PHYSICAL ISSUE 64 0.0088
52 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 43 0.0085
53 ANAL PROLAPSE 1 0.0085
54 IRON DEFICIENCY 38 0.0084
55 HYPOPHOSPHATAEMIA 62 0.0084
56 MYASTHENIA GRAVIS 67 0.0083
57 AMYLASE ABNORMAL 1 0.0080
58 ACETONAEMIA 2 0.0079
59 DIABETIC KETOSIS 3 0.0079
60 GLAUCOMA SURGERY 2 0.0078
61 INFUSION SITE IRRITATION 10 0.0078
62 APPENDICITIS 72 0.0077
63 PRODUCT APPEARANCE CONFUSION 7 0.0076
64 PANCREATIC STEATOSIS 2 0.0074
65 BLADDER NEOPLASM SURGERY 1 0.0072
66 RETINAL OPERATION 2 0.0072
67 NEWBORN PERSISTENT PULMONARY HYPERTENSION 2 0.0071
68 PLEURITIC PAIN 19 0.0069
69 MALABSORPTION FROM INJECTION SITE 2 0.0065
70 AMNIOCENTESIS ABNORMAL 1 0.0064
71 SERUM SICKNESS-LIKE REACTION 4 0.0064
72 RESPIRATORY SYMPTOM 18 0.0063
73 ACID FAST BACILLI INFECTION 1 0.0062
74 DIABETIC HYPERGLYCAEMIC COMA 2 0.0061
75 VENTRICULAR FIBRILLATION 68 0.0061
76 FOETAL EXPOSURE DURING DELIVERY 4 0.0059
77 DEVICE LOOSENING 5 0.0058
78 BLOOD KETONE BODY 2 0.0058
79 DIABETES MELLITUS INADEQUATE CONTROL 99 0.0056
80 TROPONIN INCREASED 42 0.0055
81 ARM AMPUTATION 1 0.0055
82 DIABETIC GASTROPARESIS 2 0.0054
83 XANTHOPSIA 2 0.0054
84 BLOOD INSULIN ABNORMAL 1 0.0053
85 CARDIOGENIC SHOCK 72 0.0050
86 OESOPHAGEAL SPASM 9 0.0049
87 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7 0.0048
88 DIABETIC KETOACIDOSIS 115 0.0048
89 BLOOD CALCIUM INCREASED 41 0.0047
90 INFUSION SITE MASS 5 0.0046
91 INFUSION SITE SCAR 2 0.0045
92 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
93 DIABETIC EYE DISEASE 2 0.0044
94 THERAPEUTIC PRODUCT EFFECT PROLONGED 2 0.0044
95 INGROWN HAIR 3 0.0043
96 SHOCK HYPOGLYCAEMIC 2 0.0042
97 CEREBRAL MICROANGIOPATHY 1 0.0042
98 CANCER IN REMISSION 1 0.0041
99 MICROALBUMINURIA 3 0.0040
100 KETOACIDOSIS 29 0.0039
101 BREATH SOUNDS ABNORMAL 19 0.0038
102 MALE ORGASMIC DISORDER 2 0.0038
103 URINE KETONE BODY PRESENT 6 0.0038
104 BLOOD GLUCOSE FLUCTUATION 41 0.0037
105 KETOSIS 4 0.0037
106 KETONURIA 3 0.0037
107 AVULSION FRACTURE 1 0.0035
108 HYPERBILIRUBINAEMIA NEONATAL 2 0.0034
109 HYPERLIPIDAEMIA 41 0.0034
110 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 4 0.0033
111 CHANGE IN SUSTAINED ATTENTION 1 0.0033
112 WRONG PRODUCT ADMINISTERED 22 0.0033
113 OSTEOMYELITIS CHRONIC 2 0.0032
114 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 55 0.0032
115 BACTERIAL INFECTION 59 0.0032
116 LIPOATROPHY 3 0.0032
117 CORRECTIVE LENS USER 3 0.0031
118 CROSS SENSITIVITY REACTION 3 0.0031
119 BLOOD VISCOSITY DECREASED 1 0.0030
120 MULTIPLE ORGAN DYSFUNCTION SYNDROME 84 0.0030
121 DIABETIC RETINOPATHY 10 0.0029
122 ASTHMA EXERCISE INDUCED 1 0.0029
123 SJS-TEN OVERLAP 2 0.0028
124 BLOOD GLUCOSE INCREASED 536 0.0028
125 INFUSION SITE INFLAMMATION 2 0.0028
126 FEAR OF DISEASE 5 0.0028
127 ANKLE ARTHROPLASTY 1 0.0028
128 BLOOD GLUCOSE DECREASED 132 0.0027
129 PRODUCT SELECTION ERROR 3 0.0027
130 HYPERGLYCAEMIA 99 0.0027
131 BLOOD TEST ABNORMAL 38 0.0027
132 ULCER 43 0.0027
133 NEURALGIA 64 0.0026
134 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
135 GOUT 47 0.0026
136 PRODUCT KNOWLEDGE DEFICIT 2 0.0026
137 PLACENTA PRAEVIA 2 0.0025
138 END STAGE RENAL DISEASE 46 0.0025
139 INCORRECT DOSE ADMINISTERED BY PRODUCT 4 0.0025
140 INFUSION SITE PAIN 32 0.0025
141 REACTION TO PRESERVATIVES 2 0.0025
142 ASCITES 72 0.0024
143 PERIORBITAL PAIN 2 0.0024
144 LIPODYSTROPHY ACQUIRED 5 0.0024
145 PRODUCT LEAKAGE 13 0.0023
146 DEVICE FAILURE 35 0.0023
147 MICTURITION URGENCY 25 0.0022
148 HYPOGLYCAEMIA 104 0.0021
149 DIABETIC COMA 6 0.0021
150 NEONATAL RESPIRATORY DISTRESS 2 0.0021
151 FOETAL DEATH 11 0.0021
152 ASPIRATION 23 0.0021
153 GLYCOSYLATED HAEMOGLOBIN INCREASED 53 0.0021
154 FOOT AMPUTATION 3 0.0021
155 OESOPHAGEAL PAIN 8 0.0020
156 ABORTION THREATENED 1 0.0020
157 HYPERCHOLESTEROLAEMIA 19 0.0020
158 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
159 INFUSION SITE DISCOMFORT 2 0.0019
160 PRODUCT DEPOSIT 3 0.0019
161 HYPERTENSIVE NEPHROPATHY 2 0.0019
162 PRODUCT STORAGE ISSUE 7 0.0018
163 DIABETIC NEUROPATHY 9 0.0018
164 NOSOCOMIAL INFECTION 4 0.0018
165 LINEAR IGA DISEASE 3 0.0018
166 FULL BLOOD COUNT ABNORMAL 19 0.0018
167 RHEUMATOID FACTOR INCREASED 2 0.0018
168 CATHETER SITE INFLAMMATION 1 0.0018
169 DRUG EFFECT VARIABLE 2 0.0018
170 PANCREATIC FAILURE 3 0.0017
171 RETINOPATHY 6 0.0016
172 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
173 GLUCOSE URINE PRESENT 2 0.0016
174 BLOOD BILIRUBIN ABNORMAL 2 0.0016
175 RALES 9 0.0015
176 IMPAIRED GASTRIC EMPTYING 21 0.0015
177 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
178 HYPONATRAEMIA 86 0.0015
179 HYPERAEMIA 3 0.0015
180 BONE OPERATION 1 0.0015
181 IRON DEFICIENCY ANAEMIA 14 0.0015
182 BRONCHITIS VIRAL 1 0.0015
183 BRONCHIECTASIS 10 0.0015
184 LYMPHOEDEMA 10 0.0014
185 CHRONIC FATIGUE SYNDROME 2 0.0014
186 THERAPEUTIC RESPONSE DELAYED 4 0.0014
187 MULTIPLE USE OF SINGLE-USE PRODUCT 8 0.0014
188 PERIPHERAL ARTERY OCCLUSION 2 0.0014
189 BLOOD GLUCOSE ABNORMAL 26 0.0014
190 HYPOGLYCAEMIC COMA 4 0.0014
191 NOROVIRUS INFECTION 2 0.0014
192 INFUSION SITE INDURATION 2 0.0013
193 ARTERIAL INJURY 1 0.0013
194 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
195 MASTICATION DISORDER 4 0.0013
196 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
197 PATELLA FRACTURE 3 0.0013
198 BLOOD ALCOHOL INCREASED 1 0.0013
199 MEDICAL DEVICE IMPLANTATION 2 0.0013
200 BLOOD CHOLESTEROL INCREASED 58 0.0012
201 HYPOGLYCAEMIA NEONATAL 2 0.0012
202 BREAST OPERATION 1 0.0012
203 JOINT INJURY 26 0.0012
204 INJECTION SITE ATROPHY 2 0.0012
205 INJECTION SITE INFLAMMATION 6 0.0012
206 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
207 SPLEEN DISORDER 2 0.0012
208 LIVER FUNCTION TEST INCREASED 25 0.0012
209 MYCOBACTERIAL INFECTION 2 0.0012
210 OTORRHOEA 2 0.0011
211 INCORRECT DOSE ADMINISTERED BY DEVICE 30 0.0011
212 WHEELCHAIR USER 5 0.0011
213 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
214 RENAL TRANSPLANT 4 0.0011
215 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
216 TRANSAMINASES INCREASED 24 0.0011
217 INJECTION SITE CELLULITIS 2 0.0011
218 BUNDLE BRANCH BLOCK 1 0.0011
219 BRAIN STEM HAEMORRHAGE 1 0.0011
220 JAUNDICE NEONATAL 2 0.0011
221 EARLY SATIETY 2 0.0010
222 DRY MOUTH 83 0.0010
223 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
224 DIABETES MELLITUS 77 0.0010
225 INFUSION SITE REACTION 3 0.0010
226 DEEP VEIN THROMBOSIS POSTOPERATIVE 2 0.0010
227 BUTTERFLY RASH 1 0.0010
228 TOE AMPUTATION 5 0.0010
229 ARTHRODESIS 1 0.0010
230 THYROID FUNCTION TEST ABNORMAL 4 0.0010
231 INFUSION SITE PRURITUS 3 0.0009
232 INFUSION SITE ERYTHEMA 8 0.0009
233 SPUTUM DISCOLOURED 9 0.0009
234 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
235 POOR PERIPHERAL CIRCULATION 4 0.0009
236 INFUSION SITE BRUISING 2 0.0009
237 MONOPLEGIA 4 0.0009
238 INJECTION SITE INFECTION 3 0.0009
239 INFUSION SITE HAEMORRHAGE 3 0.0009
240 WALKING AID USER 6 0.0009
241 DIABETIC NEPHROPATHY 2 0.0009
242 SLEEP DISORDER 64 0.0009
243 EXPIRED DEVICE USED 3 0.0009
244 BLOOD CREATINE INCREASED 4 0.0009
245 THIRST 16 0.0009
246 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
247 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
248 DRUG EFFECT DELAYED 4 0.0009
249 DEVICE MECHANICAL ISSUE 12 0.0009
250 INTENTIONAL PRODUCT MISUSE 76 0.0009
251 REACTION TO EXCIPIENT 2 0.0009
252 SWELLING 81 0.0009
253 INFUSION SITE INFECTION 2 0.0009
254 CORONARY ARTERY DISEASE 26 0.0009
255 ABDOMINAL DISTENSION 88 0.0008
256 CATARACT OPERATION 5 0.0008
257 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 168 0.0008
258 GENERAL PHYSICAL HEALTH DETERIORATION 95 0.0008
259 SEPSIS 91 0.0008
260 HYPOMANIA 3 0.0008
261 DERMAL CYST 2 0.0008
262 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
263 THROMBOSIS 65 0.0008
264 INJECTION SITE ABSCESS 2 0.0008
265 INFREQUENT BOWEL MOVEMENTS 2 0.0008
266 AMPUTATION 1 0.0008
267 AORTIC VALVE REPLACEMENT 1 0.0008
268 PRODUCT COMMUNICATION ISSUE 7 0.0008
269 PRODUCT PHYSICAL ISSUE 16 0.0008
270 ABORTION MISSED 1 0.0008
271 APPENDICITIS PERFORATED 2 0.0008
272 DIABETIC COMPLICATION 2 0.0008
273 BLOOD CREATININE INCREASED 51 0.0008
274 LACTOSE INTOLERANCE 2 0.0008
275 MENOPAUSE 2 0.0008
276 PRODUCT QUALITY ISSUE 105 0.0008
277 RETINAL DISORDER 2 0.0008
278 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
279 DRUG INTOLERANCE 73 0.0008
280 CARDIOVASCULAR DISORDER 19 0.0007
281 BODY MASS INDEX INCREASED 1 0.0007
282 TRIGGER FINGER 3 0.0007
283 ANAPHYLACTOID REACTION 3 0.0007
284 SPINAL STENOSIS 3 0.0007
285 CYSTIC FIBROSIS 4 0.0007
286 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
287 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
288 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
289 BLOOD ELECTROLYTES DECREASED 1 0.0007
290 PANCREATIC CARCINOMA METASTATIC 2 0.0007
291 INJECTION SITE SCAR 2 0.0007
292 PRODUCT DISPENSING ISSUE 3 0.0007
293 PULMONARY EMBOLISM 66 0.0007
294 VASCULAR GRAFT 2 0.0007
295 HYPERTONIC BLADDER 2 0.0007
296 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
297 PRODUCT LABEL CONFUSION 4 0.0007
298 SLEEP APNOEA SYNDROME 13 0.0007
299 ANKLE OPERATION 1 0.0007
300 WRONG DRUG ADMINISTERED 6 0.0007
301 DIABETIC FOOT 2 0.0007
302 ECTOPIC PREGNANCY 2 0.0006
303 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
304 HUNGER 9 0.0006
305 INJECTION SITE HYPERSENSITIVITY 2 0.0006
306 INFUSION SITE SWELLING 4 0.0006
307 POLYMYALGIA RHEUMATICA 2 0.0006
308 LIMB OPERATION 3 0.0006
309 LOWER LIMB FRACTURE 12 0.0006
310 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
311 AORTIC VALVE DISEASE 1 0.0006
312 BACTERIAL SEPSIS 2 0.0006
313 HICCUPS 5 0.0006
314 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
315 NEAR DEATH EXPERIENCE 2 0.0006
316 ORGANISING PNEUMONIA 3 0.0006
317 PULMONARY MASS 9 0.0006
318 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
319 MUSCULOSKELETAL STIFFNESS 52 0.0006
320 BLOOD CHLORIDE INCREASED 1 0.0006
321 PLEURAL EFFUSION 35 0.0006
322 FIBRIN D DIMER INCREASED 2 0.0006
323 PRODUCT CONTAMINATION 2 0.0006
324 PYODERMA GANGRENOSUM 2 0.0006
325 CAROTID ARTERY OCCLUSION 2 0.0005
326 DEVICE DELIVERY SYSTEM ISSUE 15 0.0005
327 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
328 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
329 PSYCHIATRIC SYMPTOM 4 0.0005
330 ARTHROPOD BITE 4 0.0005
331 HYPOACUSIS 23 0.0005
332 ADENOCARCINOMA OF COLON 1 0.0005
333 BONE MARROW TRANSPLANT 1 0.0005
334 INCREASED APPETITE 10 0.0005
335 PULMONARY FIBROSIS 10 0.0005
336 DEVICE DEFECTIVE 9 0.0005
337 ALCOHOL INTERACTION 1 0.0005
338 DEVICE INFORMATION OUTPUT ISSUE 4 0.0005
339 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
340 ACUTE HEPATIC FAILURE 7 0.0005
341 WOUND SECRETION 2 0.0005
342 URINE ODOUR ABNORMAL 3 0.0005
343 DISABILITY 10 0.0005
344 RENAL CYST 4 0.0005
345 ACCIDENT 6 0.0005
346 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
347 HAEMOPTYSIS 14 0.0005
348 BLINDNESS UNILATERAL 7 0.0005
349 CONSTIPATION 108 0.0005
350 FRUSTRATION TOLERANCE DECREASED 4 0.0005
351 ABDOMINAL PAIN 115 0.0005
352 VITAMIN B12 DEFICIENCY 2 0.0005
353 SOMNOLENCE 99 0.0005
354 PRODUCT STORAGE ERROR 43 0.0005
355 LEG AMPUTATION 2 0.0005
356 PARAESTHESIA ORAL 7 0.0005
357 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
358 SLEEP TERROR 2 0.0005
359 LIVER DISORDER 21 0.0005
360 LUNG DISORDER 23 0.0005
361 BLOOD TESTOSTERONE INCREASED 1 0.0005
362 OEDEMA PERIPHERAL 56 0.0005
363 PRODUCT DISPENSING ERROR 10 0.0005
364 GASTROINTESTINAL DISORDER 41 0.0005
365 INTENTIONAL DEVICE MISUSE 2 0.0005
366 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
367 CATHETERISATION CARDIAC 2 0.0005
368 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
369 RHINITIS ALLERGIC 2 0.0004
370 BRAIN FOG 7 0.0004
371 MENINGITIS ASEPTIC 2 0.0004
372 DEVICE MALFUNCTION 31 0.0004
373 EAR DISORDER 2 0.0004
374 MYOCARDITIS 5 0.0004
375 RETINAL DETACHMENT 4 0.0004
376 RENAL FUNCTION TEST ABNORMAL 2 0.0004
377 COORDINATION ABNORMAL 6 0.0004
378 PAPULE 3 0.0004
379 SKIN ABRASION 2 0.0004
380 RETINAL HAEMORRHAGE 3 0.0004
381 PRE-ECLAMPSIA 2 0.0004
382 DEAFNESS 11 0.0004
383 FEMUR FRACTURE 13 0.0004
384 VISUAL FIELD DEFECT 3 0.0004
385 MATERNAL EXPOSURE DURING PREGNANCY 37 0.0004
386 ERUCTATION 8 0.0004
387 FLUID RETENTION 21 0.0004
388 VISUAL IMPAIRMENT 51 0.0004
389 FIBROMYALGIA 10 0.0004
390 APATHY 6 0.0004
391 PHARYNGEAL SWELLING 4 0.0004
392 PANCREATIC DISORDER 2 0.0004
393 CARTILAGE INJURY 1 0.0004
394 FEELING DRUNK 3 0.0004
395 ABDOMINAL TENDERNESS 2 0.0004
396 ERYSIPELAS 2 0.0004
397 BRAIN ABSCESS 1 0.0004
398 FEMORAL NECK FRACTURE 2 0.0004
399 CATHETER SITE PAIN 1 0.0004
400 RESTLESS LEGS SYNDROME 7 0.0004
401 MALABSORPTION 2 0.0004
402 AFFECTIVE DISORDER 3 0.0004
403 INJECTION SITE DISCOMFORT 4 0.0004
404 FOOD CRAVING 2 0.0004
405 PREMATURE DELIVERY 6 0.0004
406 HEPATIC STEATOSIS 7 0.0004
407 ANIMAL BITE 1 0.0004
408 EYE HAEMORRHAGE 5 0.0004
409 INJECTION SITE DISCHARGE 2 0.0004
410 BRUXISM 2 0.0004
411 ANORGASMIA 1 0.0004
412 ASPHYXIA 3 0.0004
413 ANAEMIA 70 0.0004
414 AUTISM SPECTRUM DISORDER 2 0.0004
415 DEAFNESS UNILATERAL 2 0.0004
416 HYPERKERATOSIS 2 0.0004
417 LIVE BIRTH 3 0.0004
418 CONDITION AGGRAVATED 108 0.0004
419 HEMIPARESIS 6 0.0004
420 VOMITING 166 0.0004
421 VENTRICULAR SEPTAL DEFECT 2 0.0003
422 BLOOD MAGNESIUM DECREASED 3 0.0003
423 ACCIDENTAL UNDERDOSE 5 0.0003
424 METABOLIC ACIDOSIS 11 0.0003
425 FACIAL PAIN 3 0.0003
426 CHOLECYSTITIS 4 0.0003
427 GASTROINTESTINAL INFECTION 3 0.0003
428 TYPE 1 DIABETES MELLITUS 2 0.0003
429 CENTRAL VENOUS CATHETERISATION 1 0.0003
430 BONE MARROW DISORDER 1 0.0003
431 INJECTION SITE VESICLES 2 0.0003
432 SPINAL OPERATION 4 0.0003
433 PHARYNGITIS 4 0.0003
434 INFUSION SITE EXTRAVASATION 2 0.0003
435 DIARRHOEA HAEMORRHAGIC 3 0.0003
436 FLANK PAIN 3 0.0003
437 BLINDNESS 13 0.0003
438 PHOTOPHOBIA 6 0.0003
439 MULTIPLE INJURIES 2 0.0003
440 PRODUCT USE COMPLAINT 5 0.0003
441 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 57 0.0003
442 THERAPEUTIC RESPONSE CHANGED 2 0.0003
443 BILE DUCT STONE 1 0.0003
444 INJECTION SITE IRRITATION 4 0.0003
445 HYPOXIA 11 0.0003
446 HAEMOGLOBIN ABNORMAL 2 0.0003
447 INCOHERENT 2 0.0003
448 LACTIC ACIDOSIS 10 0.0003
449 BLOOD POTASSIUM INCREASED 5 0.0003
450 HYPERTENSION 65 0.0003
451 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
452 RENAL TUBULAR NECROSIS 3 0.0003
453 KNEE OPERATION 3 0.0003
454 LIGAMENT SPRAIN 3 0.0003
455 INABILITY TO AFFORD MEDICATION 3 0.0003
456 APPETITE DISORDER 2 0.0003
457 OVARIAN CYST 3 0.0003
458 DEVICE LEAKAGE 13 0.0003
459 SKIN MASS 2 0.0003
460 GAIT INABILITY 10 0.0003
461 BLOOD UREA INCREASED 5 0.0003
462 SINUS CONGESTION 4 0.0003
463 TOOTH ABSCESS 3 0.0003
464 ASTHMA 33 0.0003
465 CORONARY ARTERY OCCLUSION 4 0.0003
466 ILLNESS 30 0.0003
467 POOR VENOUS ACCESS 3 0.0003
468 DEVICE ISSUE 26 0.0003
469 PRODUCT ODOUR ABNORMAL 3 0.0003
470 DEVICE OCCLUSION 4 0.0003
471 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
472 TINNITUS 13 0.0003
473 INTENTIONAL DOSE OMISSION 8 0.0003
474 APPENDICECTOMY 1 0.0003
475 ISCHAEMIC STROKE 5 0.0003
476 ANGINA PECTORIS 8 0.0003
477 RENAL DISORDER 13 0.0003
478 DISTURBANCE IN ATTENTION 15 0.0003
479 APPARENT DEATH 1 0.0003
480 CHOLELITHIASIS 9 0.0003
481 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
482 GASTROINTESTINAL PAIN 3 0.0003
483 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
484 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
485 NERVE INJURY 3 0.0003
486 IMMUNODEFICIENCY 4 0.0003
487 PREMATURE BABY 8 0.0003
488 TREMOR 44 0.0003
489 APHASIA 8 0.0003
490 LACRIMATION INCREASED 8 0.0003
491 COLITIS 10 0.0003
492 SCAB 3 0.0003
493 COVID-19 46 0.0003
494 ACIDOSIS 2 0.0003
495 GLAUCOMA 5 0.0003
496 THROAT TIGHTNESS 7 0.0003
497 ATRIOVENTRICULAR BLOCK 2 0.0003
498 ANKLE FRACTURE 4 0.0003
499 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
500 RASH PRURITIC 14 0.0003
501 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
502 LIMB INJURY 7 0.0003
503 CARDIOPULMONARY FAILURE 1 0.0003
504 CERVIX CARCINOMA 1 0.0003
505 BALANCE DISORDER 22 0.0003
506 COVID-19 PNEUMONIA 3 0.0003
507 BLOOD IRON DECREASED 3 0.0003
508 HEAD INJURY 8 0.0003
509 PRODUCT PRESCRIBING ERROR 6 0.0003
510 CATARACT 15 0.0003
511 CYSTITIS 8 0.0003
512 MACULAR DEGENERATION 3 0.0003
513 ABSCESS 4 0.0003
514 WOUND 7 0.0003
515 WEIGHT INCREASED 56 0.0002
516 BLOOD DISORDER 2 0.0002
517 ABORTION SPONTANEOUS 10 0.0002
518 SPINAL FRACTURE 5 0.0002
519 LOCALISED INFECTION 6 0.0002
520 STENT PLACEMENT 2 0.0002
521 NAUSEA 196 0.0002
522 MENTAL IMPAIRMENT 6 0.0002
523 FEEDING DISORDER 5 0.0002
524 HYPERSOMNIA 7 0.0002
525 EYE DISORDER 8 0.0002
526 ABNORMAL WEIGHT GAIN 3 0.0002
527 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
528 ILEUS 3 0.0002
529 EXPOSURE DURING PREGNANCY 15 0.0002
530 LIP SWELLING 8 0.0002
531 ATRIAL SEPTAL DEFECT 2 0.0002
532 HAEMODIALYSIS 2 0.0002
533 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
534 AORTIC VALVE INCOMPETENCE 1 0.0002
535 ABSCESS LIMB 1 0.0002
536 RETCHING 5 0.0002
537 HOSPITALISATION 36 0.0002
538 PSEUDOMONAS INFECTION 2 0.0002
539 BLOOD POTASSIUM DECREASED 7 0.0002
540 CARDIAC OPERATION 2 0.0002
541 HIATUS HERNIA 3 0.0002
542 PYELONEPHRITIS 2 0.0002
543 SKIN SWELLING 2 0.0002
544 CHAPPED LIPS 1 0.0002
545 RASH MACULAR 8 0.0002
546 BEDRIDDEN 3 0.0002
547 IMMUNE SYSTEM DISORDER 3 0.0002
548 TOOTH INFECTION 3 0.0002
549 COLD SWEAT 4 0.0002
550 LOSS OF CONSCIOUSNESS 29 0.0002
551 LETHARGY 13 0.0002
552 SWOLLEN TONGUE 7 0.0002
553 BRAIN NEOPLASM MALIGNANT 1 0.0002
554 DRUG EFFECT DECREASED 12 0.0002
555 ANAL INCONTINENCE 2 0.0002
556 HEART RATE IRREGULAR 5 0.0002
557 HAEMORRHAGE 23 0.0002
558 MOOD ALTERED 6 0.0002
559 PRODUCT AVAILABILITY ISSUE 5 0.0002
560 HIDRADENITIS 2 0.0002
561 EXOSTOSIS 2 0.0002
562 PRODUCT DOSE OMISSION ISSUE 64 0.0002
563 INJECTION SITE MASS 8 0.0002
564 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
565 MEDICATION ERROR 12 0.0002
566 ROAD TRAFFIC ACCIDENT 9 0.0002
567 DEMENTIA 6 0.0002
568 CARPAL TUNNEL SYNDROME 3 0.0002
569 NEPHROPATHY 2 0.0002
570 PERIPHERAL SWELLING 33 0.0002
571 COGNITIVE DISORDER 10 0.0002
572 SKIN REACTION 3 0.0002
573 DYSPNOEA EXERTIONAL 8 0.0002
574 BLOOD SODIUM DECREASED 4 0.0002
575 FEELING JITTERY 4 0.0002
576 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
577 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
578 POST PROCEDURAL COMPLICATION 4 0.0002
579 AFFECT LABILITY 2 0.0002
580 PANCREATIC CARCINOMA 6 0.0002
581 ANOSMIA 3 0.0002
582 PRESYNCOPE 5 0.0002
583 AUTOIMMUNE DISORDER 2 0.0002
584 COELIAC DISEASE 2 0.0002
585 VITREOUS FLOATERS 2 0.0002
586 BRONCHITIS 15 0.0002
587 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
588 PNEUMONIA ASPIRATION 5 0.0002
589 BRAIN INJURY 2 0.0002
590 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
591 TASTE DISORDER 4 0.0002
592 DEVICE BREAKAGE 8 0.0002
593 DRY THROAT 2 0.0002
594 DISCOMFORT 12 0.0002
595 PALPITATIONS 23 0.0002
596 AMMONIA INCREASED 1 0.0002
597 HIP ARTHROPLASTY 3 0.0002
598 INITIAL INSOMNIA 2 0.0002
599 EAR DISCOMFORT 2 0.0002
600 THYROID DISORDER 3 0.0002
601 ABDOMINAL PAIN UPPER 40 0.0002
602 ASTHENIA 73 0.0002
603 FLATULENCE 11 0.0002
604 MUSCULOSKELETAL CHEST PAIN 3 0.0002
605 DELUSION 3 0.0002
606 DIPLOPIA 5 0.0002
607 C-REACTIVE PROTEIN INCREASED 7 0.0002
608 APLASTIC ANAEMIA 1 0.0002
609 NERVOUSNESS 10 0.0002
610 DRUG INEFFECTIVE 251 0.0002
611 BLOOD LACTIC ACID INCREASED 1 0.0002
612 OFF LABEL USE 166 0.0002
613 NEUROPATHY PERIPHERAL 18 0.0002
614 SUDDEN DEATH 2 0.0002
615 PNEUMONIA 61 0.0002
616 SCIATICA 3 0.0002
617 EYE SWELLING 7 0.0002
618 URINARY TRACT INFECTION 32 0.0002
619 MOVEMENT DISORDER 6 0.0002
620 HYPERHIDROSIS 24 0.0002
621 POOR QUALITY SLEEP 4 0.0002
622 HALLUCINATION 14 0.0002
623 WHEEZING 11 0.0002
624 BURNING SENSATION 13 0.0002
625 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
626 OEDEMA 10 0.0002
627 SKIN LACERATION 2 0.0002
628 ACUTE KIDNEY INJURY 28 0.0002
629 DYSPEPSIA 18 0.0002
630 DIZZINESS 91 0.0002
631 THERAPEUTIC RESPONSE DECREASED 11 0.0002
632 DENTAL CARIES 2 0.0002
633 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
634 VIRAL INFECTION 6 0.0002
635 ANGIOPATHY 1 0.0002
636 TYPE 2 DIABETES MELLITUS 6 0.0002
637 INTESTINAL PERFORATION 2 0.0002
638 PANCREATITIS ACUTE 4 0.0002
639 BLOOD CALCIUM DECREASED 2 0.0002
640 CANDIDA INFECTION 3 0.0002
641 EYE PAIN 10 0.0002
642 EYE INFECTION 2 0.0002
643 MYOCARDIAL ISCHAEMIA 2 0.0002
644 WEIGHT DECREASED 49 0.0002
645 SCAR 3 0.0002
646 CHOLECYSTECTOMY 2 0.0002
647 INTERNAL HAEMORRHAGE 2 0.0002
648 SUICIDAL IDEATION 16 0.0002
649 PARANOIA 3 0.0002
650 SEIZURE 20 0.0002
651 URTICARIA 29 0.0002
652 EXTRA DOSE ADMINISTERED 7 0.0002
653 PSORIATIC ARTHROPATHY 7 0.0002
654 ORTHOSTATIC HYPOTENSION 3 0.0002
655 CAESAREAN SECTION 2 0.0002
656 SPLENOMEGALY 2 0.0002
657 SEXUAL DYSFUNCTION 2 0.0002
658 INFLUENZA 19 0.0002
659 DEPRESSED MOOD 9 0.0002
660 FATIGUE 132 0.0002
661 URINARY INCONTINENCE 5 0.0002
662 DISEASE RECURRENCE 8 0.0002
663 DECREASED APPETITE 39 0.0002
664 POLLAKIURIA 7 0.0002
665 DYSPNOEA 95 0.0002
666 MIGRAINE 16 0.0002
667 PRODUCTIVE COUGH 8 0.0002
668 VISION BLURRED 23 0.0002
669 WRIST FRACTURE 2 0.0002
670 BLOOD PRESSURE FLUCTUATION 4 0.0002
671 IRRITABILITY 10 0.0002
672 INJECTION SITE PAIN 51 0.0002
673 MYOCARDIAL INFARCTION 29 0.0002
674 BLOOD PRESSURE DECREASED 11 0.0002
675 STOMATITIS 10 0.0002
676 INJECTION SITE PRURITUS 11 0.0002
677 ACCIDENTAL OVERDOSE 6 0.0002
678 CYTOPENIA 2 0.0002
679 MUSCLE SPASTICITY 2 0.0002
680 OROPHARYNGEAL PAIN 15 0.0002
681 TENDON RUPTURE 2 0.0002
682 HYPERCALCAEMIA 2 0.0002
683 CONJUNCTIVITIS 3 0.0002
684 ANXIETY 46 0.0002
685 AGEUSIA 4 0.0002
686 BLISTER 9 0.0002
687 HEPATIC CIRRHOSIS 3 0.0002
688 CEREBROVASCULAR ACCIDENT 27 0.0002
689 INFECTION 23 0.0002
690 CELLULITIS 8 0.0002
691 FEELING ABNORMAL 38 0.0002
692 FOOT FRACTURE 3 0.0002
693 BLOOD URINE PRESENT 3 0.0002
694 CHRONIC KIDNEY DISEASE 12 0.0002
695 PROTEINURIA 3 0.0002
696 DEHYDRATION 21 0.0002
697 MOOD SWINGS 5 0.0002
698 INTRAOCULAR PRESSURE INCREASED 2 0.0002
699 HEPATITIS 4 0.0002
700 CHOLESTASIS 3 0.0002
701 THROAT IRRITATION 7 0.0002
702 ROTATOR CUFF SYNDROME 2 0.0002
703 SKIN ULCER 4 0.0002
704 INJECTION SITE INDURATION 2 0.0002
705 SURGERY 9 0.0002
706 INJECTION SITE ERYTHEMA 19 0.0002
707 BRADYPHRENIA 1 0.0002
708 MALAISE 67 0.0002
709 MUSCLE SPASMS 28 0.0002
710 ARTHRITIS 12 0.0002
711 IMPAIRED HEALING 5 0.0002
712 SARS-COV-2 TEST POSITIVE 2 0.0002
713 DYSMENORRHOEA 2 0.0002
714 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
715 EXPIRED PRODUCT ADMINISTERED 5 0.0002
716 CARDIAC FAILURE ACUTE 1 0.0001
717 FUNGAL INFECTION 5 0.0001
718 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
719 MALIGNANT MELANOMA 2 0.0001
720 INJURY ASSOCIATED WITH DEVICE 3 0.0001
721 HYPOAESTHESIA 22 0.0001
722 ABNORMAL LOSS OF WEIGHT 1 0.0001
723 BLOOD TESTOSTERONE DECREASED 1 0.0001
724 PRURITUS 56 0.0001
725 HYPERSENSITIVITY 27 0.0001
726 CONTUSION 14 0.0001
727 BLOOD PRESSURE INCREASED 22 0.0001
728 AUTOIMMUNE HEPATITIS 1 0.0001
729 COUGH 40 0.0001
730 KNEE ARTHROPLASTY 3 0.0001
731 HEART RATE DECREASED 5 0.0001
732 DIALYSIS 2 0.0001
733 INCORRECT DOSE ADMINISTERED 32 0.0001
734 SUBDURAL HAEMATOMA 2 0.0001
735 PARALYSIS 2 0.0001
736 SKIN CANCER 3 0.0001
737 EYE IRRITATION 8 0.0001
738 PRURITUS GENERALISED 3 0.0001
739 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
740 FALL 46 0.0001
741 HYPERTHYROIDISM 2 0.0001
742 INJECTION SITE BRUISING 11 0.0001
743 DIARRHOEA 89 0.0001
744 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
745 HEADACHE 86 0.0001
746 ABDOMINAL DISCOMFORT 23 0.0001
747 GASTROENTERITIS 2 0.0001
748 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
749 DEPRESSION 31 0.0001
750 PYREXIA 47 0.0001
751 SNEEZING 3 0.0001
752 RESPIRATORY DISORDER 4 0.0001
753 PAIN 82 0.0001
754 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
755 ILL-DEFINED DISORDER 8 0.0001
756 INSOMNIA 35 0.0001
757 RENAL IMPAIRMENT 11 0.0001
758 INJECTION SITE REACTION 9 0.0001
759 BOWEL MOVEMENT IRREGULARITY 1 0.0001
760 SKIN DISCOLOURATION 6 0.0001
761 LYMPHOMA 2 0.0001
762 APHTHOUS ULCER 1 0.0001
763 APNOEA 1 0.0001
764 RENAL FAILURE 17 0.0001
765 TREATMENT NONCOMPLIANCE 7 0.0001
766 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
767 CHEST DISCOMFORT 13 0.0001
768 ARRHYTHMIA 6 0.0001
769 PAIN IN EXTREMITY 37 0.0001
770 OBESITY 2 0.0001
771 NECK PAIN 7 0.0001
772 MEMORY IMPAIRMENT 17 0.0001
773 MUSCLE TIGHTNESS 2 0.0001
774 BACK DISORDER 2 0.0001
775 SWELLING FACE 8 0.0001
776 AGITATION 9 0.0001
777 STAPHYLOCOCCAL INFECTION 4 0.0001
778 DRY EYE 6 0.0001
779 SYNCOPE 12 0.0001
780 URINARY RETENTION 4 0.0001
781 HOT FLUSH 9 0.0001
782 PERICARDITIS 2 0.0001
783 EYE PRURITUS 4 0.0001
784 FACE OEDEMA 2 0.0001
785 ANGER 4 0.0001
786 FLUSHING 12 0.0001
787 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
788 MYALGIA 20 0.0001
789 HYPOPHAGIA 3 0.0001
790 DRUG RESISTANCE 3 0.0001
791 CARDIAC MURMUR 1 0.0001
792 SUICIDE ATTEMPT 7 0.0001
793 RESPIRATORY TRACT INFECTION 3 0.0001
794 MUSCULAR WEAKNESS 13 0.0001
795 DEVICE USE ISSUE 2 0.0001
796 NEUROTOXICITY 2 0.0001
797 AMENORRHOEA 2 0.0001
798 HYPERKALAEMIA 4 0.0001
799 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
800 HEAD DISCOMFORT 2 0.0001
801 EAR INFECTION 3 0.0001
802 CARDIAC FAILURE CONGESTIVE 9 0.0001
803 PRODUCT USE ISSUE 21 0.0001
804 PULMONARY OEDEMA 5 0.0001
805 JAUNDICE 3 0.0001
806 HEART RATE INCREASED 11 0.0001
807 GASTROENTERITIS VIRAL 2 0.0001
808 LEUKOCYTOSIS 2 0.0001
809 TOOTHACHE 2 0.0001
810 RESTLESSNESS 4 0.0001
811 SKIN IRRITATION 5 0.0001
812 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
813 DYSURIA 4 0.0001
814 ABNORMAL DREAMS 3 0.0001
815 HYPOKALAEMIA 5 0.0001
816 JOINT SWELLING 13 0.0001
817 AGRANULOCYTOSIS 2 0.0001
818 HEPATIC FUNCTION ABNORMAL 4 0.0001
819 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
820 OXYGEN SATURATION DECREASED 6 0.0001
821 DYSARTHRIA 4 0.0001
822 ARTERIOSCLEROSIS 1 0.0001
823 ABORTION INDUCED 1 0.0001
824 COMA 5 0.0001
825 INJECTION SITE SWELLING 8 0.0001
826 HERNIA 2 0.0001
827 LIVER FUNCTION TEST ABNORMAL 3 0.0001
828 DYSPHONIA 6 0.0001
829 DRUG DOSE OMISSION BY DEVICE 8 0.0001
830 BODY TEMPERATURE DECREASED 1 0.0001
831 TACHYCARDIA 9 0.0001
832 SINUS DISORDER 2 0.0001
833 DISORIENTATION 4 0.0001
834 BLADDER DISORDER 1 0.0001
835 INJECTION SITE HAEMORRHAGE 8 0.0001
836 GAIT DISTURBANCE 19 0.0001
837 CONFUSIONAL STATE 16 0.0001
838 PRODUCT ADMINISTRATION ERROR 2 0.0001
839 VERTIGO 6 0.0001
840 FEELING HOT 6 0.0001
841 INJECTION SITE RASH 3 0.0001
842 SINUSITIS 10 0.0001
843 CHEST PAIN 18 0.0001
844 PERITONITIS 2 0.0001
845 TOOTH LOSS 2 0.0001
846 CARDIAC DISORDER 9 0.0001
847 NERVOUS SYSTEM DISORDER 3 0.0001
848 RHABDOMYOLYSIS 4 0.0001
849 ECZEMA 5 0.0001
850 DERMATITIS 2 0.0001
851 DRUG INTERACTION 15 0.0001
852 EATING DISORDER 2 0.0001
853 IMPAIRED WORK ABILITY 2 0.0001
854 NIGHT SWEATS 3 0.0001
855 DEVICE DISLOCATION 4 0.0001
856 BIPOLAR DISORDER 1 0.0001
857 BACK INJURY 1 0.0001
858 SEPTIC SHOCK 4 0.0001
859 MENTAL DISORDER 4 0.0001
860 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
861 ANAPHYLACTIC REACTION 5 0.0001
862 ANGIOEDEMA 4 0.0001
863 BACK PAIN 21 0.0001
864 SKIN DISORDER 3 0.0001
865 RASH MACULO-PAPULAR 2 0.0001
866 NEOPLASM MALIGNANT 6 0.0001
867 RASH 39 0.0001
868 GLOSSODYNIA 2 0.0001
869 PRODUCT SUBSTITUTION ISSUE 5 0.0001
870 NIGHTMARE 3 0.0001
871 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
872 OCULAR HYPERAEMIA 4 0.0001
873 BACTERAEMIA 1 0.0001
874 HEPATIC CANCER 2 0.0001
875 ERYTHEMA 17 0.0001
876 BURSITIS 1 0.0001
877 ADRENAL INSUFFICIENCY 1 0.0001
878 PANIC ATTACK 3 0.0001
879 ARTHRALGIA 34 0.0001
880 ENCEPHALOPATHY 2 0.0001
881 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
882 LEUKOPENIA 4 0.0001
883 HYPOTENSION 16 0.0001
884 INTESTINAL OBSTRUCTION 3 0.0001
885 ABDOMINAL PAIN LOWER 2 0.0001
886 HAEMATEMESIS 2 0.0001
887 INTENTIONAL OVERDOSE 5 0.0001
888 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
889 INFLAMMATION 4 0.0001
890 RHINORRHOEA 5 0.0001
891 RASH GENERALISED 2 0.0001
892 PARAESTHESIA 12 0.0001
893 GASTRITIS 2 0.0001
894 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
895 PANCREATITIS 4 0.0001
896 DRY SKIN 10 0.0001
897 MENSTRUATION IRREGULAR 2 0.0001
898 BLOOD BILIRUBIN INCREASED 2 0.0001
899 FREQUENT BOWEL MOVEMENTS 2 0.0001
900 LUNG NEOPLASM MALIGNANT 3 0.0001
901 MENTAL STATUS CHANGES 2 0.0001
902 FEELING COLD 2 0.0001
903 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
904 NASOPHARYNGITIS 13 0.0001
905 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
906 BRONCHOSPASM 1 0.0001
907 HERPES ZOSTER 4 0.0001
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
909 VAGINAL HAEMORRHAGE 3 0.0001
910 CHILLS 8 0.0001
911 CARDIOMYOPATHY 1 0.0001
912 RENAL INJURY 2 0.0001
913 BONE LOSS 1 0.0001
914 UNEVALUABLE EVENT 5 0.0001
915 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
916 NEPHROLITHIASIS 3 0.0001
917 DEATH 56 0.0001
918 LIMB DISCOMFORT 2 0.0001
919 DRUG-INDUCED LIVER INJURY 2 0.0001
920 HYPOTHYROIDISM 2 0.0001
921 CARDIAC FAILURE 5 0.0001
922 INTERSTITIAL LUNG DISEASE 3 0.0001
923 RHEUMATOID ARTHRITIS 7 0.0001
924 AMNESIA 4 0.0001
925 PSORIASIS 8 0.0001
926 AGGRESSION 3 0.0001
927 HAEMATURIA 2 0.0001
928 GASTRIC DISORDER 2 0.0001
929 MUSCULOSKELETAL PAIN 3 0.0001
930 SPEECH DISORDER 3 0.0001
931 BRADYCARDIA 3 0.0001
932 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
933 CEREBRAL HAEMORRHAGE 2 0.0001
934 MOBILITY DECREASED 4 0.0001
935 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
936 DRUG EFFECT INCOMPLETE 2 0.0001
937 BONE DISORDER 1 0.0001
938 ARTHROPATHY 3 0.0001
939 PANCYTOPENIA 3 0.0001
940 THROMBOCYTOPENIA 6 0.0001
941 ATRIAL FIBRILLATION 5 0.0001
942 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
943 PLASMA CELL MYELOMA 2 0.0001
944 CHOKING 1 0.0001
945 BONE PAIN 3 0.0001
946 NASAL CONGESTION 3 0.0001
947 ABNORMAL BEHAVIOUR 2 0.0001
948 BLOOD PRESSURE ABNORMAL 1 0.0001
949 BODY TEMPERATURE INCREASED 1 0.0000
950 WITHDRAWAL SYNDROME 2 0.0000
951 SKIN EXFOLIATION 4 0.0000
952 PRODUCT DOSE OMISSION 3 0.0000
953 DEVICE DIFFICULT TO USE 3 0.0000
954 COLITIS ULCERATIVE 2 0.0000
955 BREAST CANCER 4 0.0000
956 MULTIPLE SCLEROSIS 2 0.0000
957 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
958 RESPIRATORY FAILURE 3 0.0000
959 THERAPY CESSATION 2 0.0000
960 ANAPHYLACTIC SHOCK 1 0.0000
961 ANHEDONIA 1 0.0000
962 DERMATITIS ATOPIC 2 0.0000
963 BREAST CANCER FEMALE 1 0.0000
964 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
965 INFLUENZA LIKE ILLNESS 3 0.0000
966 HAEMATOCHEZIA 2 0.0000
967 DRUG ABUSE 3 0.0000
968 ALOPECIA 7 0.0000
969 ACUTE MYOCARDIAL INFARCTION 1 0.0000
970 ADVERSE DRUG REACTION 3 0.0000
971 EMOTIONAL DISTRESS 4 0.0000
972 DYSPHAGIA 3 0.0000
973 FEBRILE NEUTROPENIA 2 0.0000
974 HEPATIC ENZYME INCREASED 2 0.0000
975 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
976 INJURY 2 0.0000
977 THERAPY INTERRUPTED 2 0.0000
978 OVERDOSE 6 0.0000
979 DYSGEUSIA 2 0.0000
980 DISEASE PROGRESSION 3 0.0000
981 TREATMENT FAILURE 2 0.0000
982 CARDIO-RESPIRATORY ARREST 1 0.0000
983 ADVERSE EVENT 2 0.0000
984 ACNE 1 0.0000
985 DRUG DEPENDENCE 2 0.0000
986 CARDIAC ARREST 1 0.0000
987 DRUG DOSE OMISSION 2 0.0000
988 TOXICITY TO VARIOUS AGENTS 2 0.0000
989 NO ADVERSE EVENT 2 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000